Bristol-Myers Squibb portfolio
36 tracked investments, 6 on the map, $1.4B raised across the mapped portfolio.
Bristol-Myers Squibb36 investments · 6 on the map · $1.4B raised- Kura OncologyPost-IPO Equity
- Treefrog Therapeutics
- Nitrase TherapeuticsSeries A
- GlycoEra
- OctantSeries B
- BigHat BiosciencesSeries B
Also in the portfolio
- Aktis Oncology
- Orna Therapeutics
- Waiv
- Capstan Therapeutics
- Q32 Bio
- Nuvig Therapeutics
- PathAI
- Ribon Therapeutics
- Asher Bio
- Be Biopharma
- SyntheX
- K36 Therapeutics
- Roswell Park Cancer Institute
- Cajal Neuroscience
- AstronauTx
- Transition Bio
- Cardior Pharmaceuticals
- Cour Pharmaceuticals Development
- Abata Therapeutics
- Attralus
- HiberCell
- Light Horse Therapeutics
- IMIDomics
- Exscientia
- iVexSol
- Ikena Oncology
- University of North Carolina at Chapel Hill School of Medicine
- Blood Cancer UK
- Instituto Oncoguia
- Drexel University
Investors similar to Bristol-Myers Squibb
Andreessen Horowitz548 investments · 482 on the map · $32.6B raised
Catalio Capital Management31 investments · 13 on the map · $1.7B raised
Sofinnova Partners56 investments · 8 on the map · $480.9M raised
Gaingels439 investments · 340 on the map · $6.1B raised
8VC192 investments · 110 on the map · $11.6B raised
XAnge77 investments · 20 on the map · $807.5M raised